Analytik Jena AG
Analytik Jena publishes preliminary figures
Ad-hoc-announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
– new sales record posted of EUR 84.5m
– 58% export ratio compensates for weak German domestic demand
– Liquid funds up more than 40%
– Earnings Figures correspond with company plans
Analytik Jena AG saw a strong sales increase of 31.4% to EUR 84.5m in financial
year 2002/2003 (to 30 September) (2001/2002: EUR 64.3m), according to
preliminary figures.
The company’s liquid funds increased considerably towards the end of the
financial year, reaching EUR 6.8m (EUR 4.8m).
AJ saw a perceivable improvement in instrument demand over the last quarter of
the past financial year, with analytical and bioanalytical systems sales rising
by 46.8% over the third quarter of the financial year to EUR 6.5m.
Project Solutions business unit sales rose 66.3% for the entire financial year
2002/2003 from EUR 34.3m to EUR 57.1m, while instrument sales in the Analytical
and Bioanalytical Solutions business units fell 9.9% to EUR 22.9m (EUR 25.4m)
due to economic and currency developments. Consumer goods sales roughly matched
the previous year’s figures at EUR 4.4m (EUR 4.5m).
Rising from EUR 11.2m to EUR 39.9m, Europe is the company’s largest regional
market. German sales fell by 23% due to continued investment hesitancy,
decreasing to EUR 35m for the financial year (EUR 45.5m). Exports increased to
58.5% (29.2%), thus compensating for the weak domestic market.
Analytik Jena continues to maintain a very high order backlog totaling EUR 96.2m
at the end of the financial year (EUR 93.7m).
In light of the currently ongoing audit process, AJ is adhering to its
previously established earnings goals. The company expects to return to positive
figures, projecting a EBIT (earnings before interest and taxes of approx. EUR
0.5m to 1.0m (EUR -1.5m).
Final figures for financial year 2002/2003 will be published on December 30,
2003.
Contact: Thomas Fritsche, Tel.:+49 (0) 3641 77-9281, Fax: +49 (0) 3641 77
9988, E-mail: t.fritsche@analytik-jena.de
end of ad-hoc-announcement (c)DGAP 04.12.2003
——————————————————————————–
WKN: 521350; ISIN: DE0005213508; Index:
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-
Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart
040832 Dez 03
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden